Sensor-Tech Laboratory

ANO "Laboratory" Sensor-Tech "was founded in 2016 with the support of the BF" Foundation for the Support of Deaf-Blind "Co-Unity." The laboratory was created for the development in Russia and the world of technologies and products for citizens with hearing and vision impairment (including deaf-blind people). Research and development topics capture areas of science and technology such as bioengineering, biotechnical systems, nanoelectronics and electrical engineering, information and communication systems, neurology and neurophysiology, genetics and other areas.

Among the projects of the Sensor-Tech Laboratory: the See My World ophthalmic VR simulator, which simulates various visual impairments; Appendix "Bill Determinant" for Blind Persons; a smart assistant for the blind "Robin" and a speech recognition device "Charlie."

• In 2017, the Sensor-Tech Laboratory participated in the first operations in Russia to install a bionic implant for people with impaired vision.
• In 2019, Sensor-Tech became a resident of the Skolkovo Foundation. The laboratory works with the support of the NeuroNet OS and the AURA-Tech Association. The Robin and Charlie projects are being implemented as part of the National Technology Initiative roadmap.

2025: Attracting ₽305 Million Investments

The Russian company Elvis has attracted ₽305 million investments from a venture capital fund "Sunrise" for the development of neuroimplants for the restoration of hearing, vision and treatment of neurological diseases. The funds will be directed to preclinical tests, refinement of the technology and preparation for the launch of products on the market. This became known in early March 2025.

By this date, the company is developing four products for various medical areas. Among them are Elvis C (cochlear implant for hearing restoration), Elvis V (implant for vision restoration), Elvis DBS (device for deep brain stimulation in neurological diseases) and Elvis BCI (brain-computer interface for rehabilitation of paralyzed people).

𝓲

Фото: Freepik

The company plans to bring all its products to the Russian market in the next four years. Elvis C is already preparing for registration and is scheduled for commercial launch in late 2026. By the beginning of March 2025, Elvis DBS is undergoing preclinical tests. The launch of vision restoration devices and brain-to-computer communication neuroimplant is slated for 2028-2029.

Ruslan Sarkisov, Managing Partner of the Voskhod Foundation, noted that the development of neurointerfaces investigated since the 1970s has now reached a stage where their commercial use is becoming the immediate prospect thanks to modern achievements in IT, medicine and electronics. It is important for the fund that the company already has products ready to enter the market in the coming years, and at the same time develops promising solutions that are applicable not only for rehabilitation, but also for expanding human capabilities.

Denis Kuleshov, General Director of Neuroimplants Elvis LLC, stressed that Elvis brain implants combine complex, unique technologies. The project team formed these competencies in its eight years of active work. Russia used to buy foreign devices and did not produce its own neuroimplants for medical use, and now Elvis is entering the market with four medical devices at once.^[1]

Notes